Overview

Rivastigmine in the Management of Delirium

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of an anticholinesterase treatment in patients aged 75 and over, hospitalized with delirium. Study type : Interventional Study design: randomized, double-blind, placebo-controlled study during one month and a 11-month follow-up
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Novartis Pharmaceuticals
Treatments:
Cholinesterase Inhibitors
Rivastigmine